Literature DB >> 32394347

Molecular changes in transcription and metabolic pathways underlying muscle atrophy in the CuZnSOD null mouse model of sarcopenia.

Kavithalakshmi Sataranatarajan1, Gavin Pharaoh1, Jacob L Brown1, Rojina Ranjit1, Katarzyna M Piekarz1, Kaitlyn Street1, Jonathan D Wren2, Constantin Georgescu2, Caroline Kinter1, Michael Kinter1, Willard M Freeman2, Arlan Richardson3,4, Holly Van Remmen5,6,7.   

Abstract

Mice lacking the superoxide anion scavenger CuZn superoxide dismutase (Sod1-/- mice) develop a number of age-related phenotypes, including an early progression of muscle atrophy and weakness (sarcopenia) associated with loss of innervation. The purpose of this study was to delineate the early development of sarcopenia in the Sod1-/- mice and to measure changes in the muscle transcriptome, proteome, and eicosanoid profile at the stage when sarcopenia is markedly induced in this model (7-9 months of age). We found a strong correlation between muscle atrophy and mitochondrial state 1 hydroperoxide production, which was 40% higher in isolated mitochondria from Sod1-/- mouse gastrocnemius muscle by 2 months of age. The primary pathways showing altered gene expression in Sod1-/- mice identified by RNA-seq transcriptomic analysis are protein ubiquitination, synaptic long-term potentiation, calcium signaling, phospholipase C signaling, AMPK, and TWEAK signaling. Targeted proteomics shows elevated expression of mitochondrial proteins, fatty acid metabolism enzymes, tricarboxylic acid (TCA) cycle enzymes, and antioxidants, while enzymes involved in carbohydrate metabolism are downregulated in Sod1-/- mice. LC-MS analysis of lipids in gastrocnemius muscle detected 78 eicosanoids, of which 31 are significantly elevated in muscle from Sod1-/- mice. These data suggest that mitochondrial hydroperoxide generation is elevated prior to muscle atrophy and may be a potential driving factor of changes in the transcriptome, proteome, and eicosanoid profile of the Sod1-/- mice. Together, these analyses revealed important molecular events that occur during muscle atrophy, which will pave the way for future studies using new approaches to treat sarcopenia.

Entities:  

Keywords:  Aging; Muscle atrophy; Oxidative stress; Reactive oxygen species (ROS); Sarcopenia; Sod1 knockout mice

Mesh:

Year:  2020        PMID: 32394347      PMCID: PMC7394980          DOI: 10.1007/s11357-020-00189-x

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.581


  94 in total

1.  Effects of CDP-choline on phospholipase A2 and cholinephosphotransferase activities following a cryogenic brain injury in the rabbit.

Authors:  E Arrigoni; N Averet; F Cohadon
Journal:  Biochem Pharmacol       Date:  1987-11-01       Impact factor: 5.858

2.  [Aging-related frailty and sarcopenia. The relationship between "inflammaging" and frailty/sarcopenia.]

Authors:  Mitsutaka Yakabe
Journal:  Clin Calcium       Date:  2018

3.  Accelerated decline in cognition in a mouse model of increased oxidative stress.

Authors:  Sreemathi Logan; Gordon H Royce; Daniel Owen; Julie Farley; Michelle Ranjo-Bishop; William E Sonntag; Sathyaseelan S Deepa
Journal:  Geroscience       Date:  2019-10-22       Impact factor: 7.713

4.  Skeletal muscle weakness due to deficiency of CuZn-superoxide dismutase is associated with loss of functional innervation.

Authors:  Lisa M Larkin; Carol S Davis; Catrina Sims-Robinson; Tatiana Y Kostrominova; Holly Van Remmen; Arlan Richardson; Eva L Feldman; Susan V Brooks
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-07       Impact factor: 3.619

5.  The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.

Authors:  Ashwani Mittal; Shephali Bhatnagar; Akhilesh Kumar; Estelle Lach-Trifilieff; Sandrine Wauters; Hong Li; Denys Y Makonchuk; David J Glass; Ashok Kumar
Journal:  J Cell Biol       Date:  2010-03-22       Impact factor: 10.539

6.  Mitochondrial Dysfunction Launches Dexamethasone-Induced Skeletal Muscle Atrophy via AMPK/FOXO3 Signaling.

Authors:  Jing Liu; Yunhua Peng; Xun Wang; Yingying Fan; Chuan Qin; Le Shi; Ying Tang; Ke Cao; Hua Li; Jiangang Long; Jiankang Liu
Journal:  Mol Pharm       Date:  2015-12-17       Impact factor: 4.939

7.  Glucocorticoids induce cytosolic phospholipase A2 and prostaglandin H synthase type 2 but not microsomal prostaglandin E synthase (PGES) and cytosolic PGES expression in cultured primary human amnion cells.

Authors:  Kang Sun; Runlin Ma; Xiaolan Cui; Begoña Campos; Rose Webster; Diane Brockman; Leslie Myatt
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

8.  Phosphoproteomics reveals conserved exercise-stimulated signaling and AMPK regulation of store-operated calcium entry.

Authors:  Marin E Nelson; Benjamin L Parker; James G Burchfield; Nolan J Hoffman; Elise J Needham; Kristen C Cooke; Timur Naim; Lykke Sylow; Naomi Xy Ling; Deanne Francis; Dougall M Norris; Rima Chaudhuri; Jonathan S Oakhill; Erik A Richter; Gordon S Lynch; Jacqueline Stöckli; David E James
Journal:  EMBO J       Date:  2019-08-05       Impact factor: 11.598

9.  Ketogenic diet induces expression of the muscle circadian gene Slc25a25 via neural pathway that might be involved in muscle thermogenesis.

Authors:  Reiko Nakao; Shigeki Shimba; Katsutaka Oishi
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

10.  Intramuscular inflammatory and resolving lipid profile responses to an acute bout of resistance exercise in men.

Authors:  Luke Vella; James F Markworth; Michelle M Farnfield; Krishna R Maddipati; Aaron P Russell; David Cameron-Smith
Journal:  Physiol Rep       Date:  2019-08
View more
  4 in total

1.  Oklahoma Nathan Shock Aging Center - assessing the basic biology of aging from genetics to protein and function.

Authors:  Holly Van Remmen; Willard M Freeman; Benjamin F Miller; Michael Kinter; Jonathan D Wren; Ann Chiao; Rheal A Towner; Timothy A Snider; William E Sonntag; Arlan Richardson
Journal:  Geroscience       Date:  2021-10-04       Impact factor: 7.713

Review 2.  Experimental Models of Sarcopenia: Bridging Molecular Mechanism and Therapeutic Strategy.

Authors:  Sakulrat Mankhong; Sujin Kim; Sohee Moon; Hyo-Bum Kwak; Dong-Ho Park; Ju-Hee Kang
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

3.  Metabolomics-Based Frailty Biomarkers in Older Chinese Adults.

Authors:  Yiming Pan; Yun Li; Pan Liu; Yaxin Zhang; Bowen Li; Zuyun Liu; Guanghou Shui; Lina Ma
Journal:  Front Med (Lausanne)       Date:  2022-01-26

4.  Targeting cPLA2 derived lipid hydroperoxides as a potential intervention for sarcopenia.

Authors:  Gavin Pharaoh; Jacob L Brown; Kavithalakshmi Sataranatarajan; Parker Kneis; Jan Bian; Rojina Ranjit; Niran Hadad; Constantin Georgescu; Peter Rabinovitch; Qitao Ran; Jonathan D Wren; Willard Freeman; Michael Kinter; Arlan Richardson; Holly Van Remmen
Journal:  Sci Rep       Date:  2020-08-18       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.